I've done a search for relevent news on GSK today. I'm not sure if this is news, or relevant, so forgive me for posting it if it is not. In simple terms, the article below claims that a part of ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

GSK has acquired exclusive global rights to progress the clinical development and commercialisation of GSK’227. Credit: MAXSHOT.PL/Shutterstock. GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug ...

8 – Chanel: The Interlocked C's of Timeless Fashion The iconic interlocked double ‘C' logo of Coco Chanel has become one of the most recognisable emblems in fashion history. Introduced in the 1920s, ...

As of 15 November at 9:37:03 am GMT-5. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

Big pharma company GSK and UK AI-biotech Relation Therapeutics have entered into two strategic collaborations to identify and validate new therapeutic targets for osteoarthritis and fibrotic diseases.

GSK has handed over $45 million upfront to fellow London-based firm Relation to help the pharma identify new targets for fibrotic diseases and osteoarthritis. The two-stranded collaboration will ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today. The company’s shares opened today at p1,388.50. Pick the best stocks and maximize ...

Ma­chine learn­ing and AI have sparked a trans­for­ma­tion in drug dis­cov­ery, but crack­ing the bi­ol­o­gy is still para­mount.

GSK’sGSK-0.34%decrease; red down pointing triangle blood-cancer drug Blenrep showed positive overall survival data in a late-stage trial, increasing the likelihood for the treatment to return to ...

GSK is now looking to start a phase 3 trial in the first-line setting shortly, Abdullah said. The DREAMM-10 study will once again pit Blenrep against Darzalex, this time as part of front-line ...

Dec 9 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Monday its experimental cancer drug Blenrep in combination with other treatments reduced the risk of death by 42% in multiple ...